TY - JOUR
T1 - An immunoassay method for the pharmacokinetics of 5-fluorouracil in patients with gastric cancer administered adjuvant chemotherapy
AU - Matsumoto, Hideo
AU - Higashida, Masaharu
AU - Kubota, Hisako
AU - Murakami, Haruaki
AU - Tsutsumi, Kosuke
AU - Nakashima, Hiroshi
AU - Oka, Yasuo
AU - Okumura, Hideo
AU - Nakamura, Masafumi
AU - Hirai, Toshihiro
PY - 2012/11/1
Y1 - 2012/11/1
N2 - Conventional gas chromatography-mass spectrometry (GC-MS) was compared with a new immunoassay method for measuring plasma (5-FU) concentrations in adjuvant chemotherapy with TS-1 for patients with gastric cancer. TS-1 was administered orally to patients after gastrectomy. Blood samples for pharmacokinetic analysis were collected on the seventh day of treatment. The mean area under the time concentration curve (AUC)0-8, half-life (t1/2), and maximum drug concentration (Cmax) obtained by the two methods were as follows: GC-MS, 847.9 μg/ml/hr, 2.76 h, and 186.6 ng/ml; and immunoassay, 1311.2 μg/ml/hr, 3.5 h, and 259.8 ng/ml. Significant correlations were observed for AUC0-8(p=0.0001), Cmax (p=0.0007), and changes in the 5-FU concentration in blood over time (p=0.018) for the two methods. Compared with the conventional GC-MS method, the new immunoassay method provides similar results, but is simpler and results can be obtained earlier. This method will be useful for monitoring the 5-FU concentration in serum from patients with gastric cancer receiving TS-1.
AB - Conventional gas chromatography-mass spectrometry (GC-MS) was compared with a new immunoassay method for measuring plasma (5-FU) concentrations in adjuvant chemotherapy with TS-1 for patients with gastric cancer. TS-1 was administered orally to patients after gastrectomy. Blood samples for pharmacokinetic analysis were collected on the seventh day of treatment. The mean area under the time concentration curve (AUC)0-8, half-life (t1/2), and maximum drug concentration (Cmax) obtained by the two methods were as follows: GC-MS, 847.9 μg/ml/hr, 2.76 h, and 186.6 ng/ml; and immunoassay, 1311.2 μg/ml/hr, 3.5 h, and 259.8 ng/ml. Significant correlations were observed for AUC0-8(p=0.0001), Cmax (p=0.0007), and changes in the 5-FU concentration in blood over time (p=0.018) for the two methods. Compared with the conventional GC-MS method, the new immunoassay method provides similar results, but is simpler and results can be obtained earlier. This method will be useful for monitoring the 5-FU concentration in serum from patients with gastric cancer receiving TS-1.
UR - http://www.scopus.com/inward/record.url?scp=84872660132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872660132&partnerID=8YFLogxK
M3 - Article
C2 - 23155289
AN - SCOPUS:84872660132
SN - 0250-7005
VL - 32
SP - 5111
EP - 5114
JO - Anticancer research
JF - Anticancer research
IS - 11
ER -
